AUM $84.7MER 2.82%NAV $19.74Holdings 19Inception Feb 2023
Price Chart
Key Statistics
Previous Close
$20.25Day Range
$20.16$21.31
52-Week Range
$15.21$20.39
Avg Volume
3.3KDividend Yield
16.00%Expense Ratio
2.82%AUM
$84.7MShares Outstanding
4.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 52.08% |
| Energy | 47.92% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 83.77% |
| Other | 8.57% |
| Canada | 4.07% |
| United Kingdom | 1.87% |
| France | 1.72% |
Fund Information
- Issuer
- Simplify
- Category
- Healthcare
- Inception Date
- Feb 7, 2023
- Exchange
- NYSE_ARCA
- Description
- The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.
Similar ETFs
The Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund issued by Simplify that launched on Feb 7, 2023. It currently manages $84.7M in assets under management. The fund charges an expense ratio of 2.82%. The fund holds 19 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 82.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | 40.27% | 1,272,360 | $34.1M |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC USD 0.001 | 13.56% | 1,432,105 | $11.5M |
| 3 | — | ACHIEVE LIFE SCIENCES I WTS 30JUN30 | 5.73% | 966,667 | $4.9M |
| 4 | DCTH | DELCATH SYS INC USD 0.01 | 5.17% | 261,126 | $4.4M |
| 5 | MIST | MILESTONE PHARMACEUTICALS INC NPV | 4.07% | 3,349,379 | $3.4M |
| 6 | CORT | CORCEPT THERAPEUTICS INC USD 0.001 | 3.78% | 26,434 | $3.2M |
| 7 | COLL | COLLEGIUM PHARMACEUTICAL USD 0.001 | 2.63% | 80,887 | $2.2M |
| 8 | PHAT | PHATHOM PHARMACEUTICALS USD 0.0001 | 2.53% | 249,267 | $2.1M |
| 9 | CLDX | CELLDEX THERAPEUTICS INC USD 0.001 | 2.51% | 53,134 | $2.1M |
| 10 | ABEO | ABEONA THERAPEUTICS INC USD 0.01 | 1.94% | 276,333 | $1.6M |
| 11 | CMPS | COMPASS PATHWAYS PLC USD 0.008 ADR | 1.87% | 114,281 | $1.6M |
| 12 | KYTX | KYVERNA THERAPEUTICS IN USD 0.00001 | 1.75% | 182,603 | $1.5M |
| 13 | IVA | INVENTIVA SA NPV ADR | 1.72% | 313,483 | $1.5M |
| 14 | AQST | AQUESTIVE THERAPEUTICS IN USD 0.001 | 1.48% | 278,723 | $1.3M |
| 15 | OBIO | ORCHESTRA BIOMED HLDGS I USD 0.0001 | 1.41% | 219,387 | $1.2M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.69% | |
| 1W | +5.08% | |
| 1M | +13.91% | |
| 3M | +14.78% | |
| 6M | +17.87% | |
| YTD | +21.67% | |
| 1Y | +28.44% | |
| 3Y | -4.77% | |
| 5Y | -17.33% |
Moving Averages
20-Day MA
$18.86
Above 20-Day MA50-Day MA
$18.20
Above 50-Day MA200-Day MA
$17.30
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$20.39
Current Price
$20.39
52-Week Low
$15.21
$15.21$20.39
Current Yield
16.00%
Annual Dividend
$2.7200
Frequency
Quarterlyx/year
Last Ex-Date
Mar 26, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Mar 26, 2026 | $0.6800 | Mar 31, 2026 |
| Dec 23, 2025 | $0.6800 | Dec 31, 2025 |
| Sep 25, 2025 | $0.6800 | Sep 30, 2025 |
| Jun 25, 2025 | $0.6800 | Jun 30, 2025 |
| Mar 26, 2025 | $0.6800 | Mar 31, 2025 |
| Dec 23, 2024 | $0.6800 | Dec 31, 2024 |
| Sep 25, 2024 | $0.6800 | Sep 30, 2024 |
| Jun 25, 2024 | $1.2500 | Jun 28, 2024 |
| Mar 25, 2024 | $0.6800 | Mar 28, 2024 |
| Dec 26, 2023 | $0.6800 | Dec 29, 2023 |
| Sep 27, 2023 | $0.6800 | Sep 29, 2023 |
| Jun 27, 2023 | $0.6800 | Jul 3, 2023 |
| Mar 27, 2023 | $1.0000 | Mar 31, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | SURI | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 2.82% | 0.62% | 0.84% |
| AUM | $84.7M | $1.98B | $1.86B |
| Dividend Yield | 16.00% | 3.90% | 1.97% |
| Avg Volume | 3.3K | 422.1K | 1.1M |
| Holdings | 19 | 167 | 65 |
| Performance | |||
| 1-Month Return | +12.28% | +6.56% | +11.19% |
| 6-Month Return | +23.23% | +16.09% | +26.77% |
| YTD Return | +21.42% | +16.75% | +27.34% |
| 1-Year Return | +13.07% | +15.10% | +23.91% |
Compare with Another ETF
Search for an ETF to compare with SURI:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.